Creo Medical Group (LON:CREO – Get Free Report)‘s stock had its “house stock” rating restated by Shore Capital Group in a research report issued on Monday,Digital Look reports. They presently have a GBX 40 target price on the stock. Shore Capital Group’s price objective would indicate a potential upside of 174.73% from the company’s previous close.
Creo Medical Group Stock Performance
LON CREO opened at GBX 14.56 on Monday. The company has a current ratio of 3.22, a quick ratio of 2.19 and a debt-to-equity ratio of 8.20. The firm has a market capitalization of £70.73 million, a price-to-earnings ratio of 14.56 and a beta of 1.62. The firm’s 50 day simple moving average is GBX 13.02 and its 200 day simple moving average is GBX 12.75. Creo Medical Group has a 1 year low of GBX 9.52 and a 1 year high of GBX 18.50.
Creo Medical Group (LON:CREO – Get Free Report) last announced its quarterly earnings data on Friday, May 22nd. The company reported GBX (0.04) earnings per share (EPS) for the quarter. Creo Medical Group had a net margin of 88.33% and a return on equity of 9.56%. The firm had revenue of GBX 600 million during the quarter. As a group, research analysts expect that Creo Medical Group will post -10.0800005 earnings per share for the current fiscal year.
About Creo Medical Group
Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.
The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.
See Also
- Five stocks we like better than Creo Medical Group
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
